Characterization of E1 enzyme dependencies in mutant-UBA1 human cells reveals UBA6 as a novel therapeutic target in VEXAS syndrome

Courtnee Clough(Cincinnati Children's Hospital Medical Center), Daniel T. Starczynowski(Cincinnati Children's Hospital Medical Center)
Leukemia
June 30, 2025
Cited by 4


Related Papers